After Hours
The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Stocks Info
The company is listed on the NASDAQ and operates within the Drug Manufacturers – General industry segment. The current market capitalization of Gilead Sciences, Inc. is $108.60B. A total of 4.37 million shares were traded on the day, compared to an average of 6.21M shares.
In the most recent transaction, Parsey Merdad sold 2,000 shares of GILD for 83.83 per share on Oct 01 ’24. After the transaction, the Chief Medical Officer now owns 100,189 company shares. In a previous transaction on Oct 01 ’24, MERDAD V PARSEY bought 2,000 shares at 83.83 per share.
Among the insiders who sold shares, Parsey Merdad disposed of 21,246 shares on Sep 12 ’24 at a per-share price of $84.50. This resulted in the Chief Medical Officer holding 102,189 shares of GILD after the transaction. In another insider transaction, Mercier Johanna sold 29,357 shares at $83.78 per share on Sep 12 ’24. Company shares held by the Chief Commercial Officer now total 78,127.
Dividend
The dividend paying company demonstrates a positive outlook for investors and helps them generate immediate cash. Gilead Sciences, Inc. pays an annual dividend of $3.06, resulting in a dividend yield of 3.51%, and it has a price to earnings (P/E) ratio of 106.61. GILD’s most recent ex-dividend date was 9/13/2024 when it declared a $0.77 quarterly dividend that was paid in cash on 9/27/2024. Previously, the company paid the dividend on 6/27/2024 with an ex-dividend date of 6/14/2024. The GILD stock dividend was $0.77 per share in cash.
It has been observed that price targets are rarely accurate, but they can exert some influence from time to time, and are often accepted as valuable in the market. In terms of 52-week highs and lows, GILD has a high of $88.36 and a low of $62.07.
Balance Sheet Annually/Quarterly
An equity investor’s investment can be viewed on a balance sheet by looking at what assets and liabilities the company has. Investors can determine the company’s prospects by calculating its financial ratios based on this information. GILD’s latest balance sheet shows that the firm has $6.52B in Cash & Short Term Investments as of fiscal 2021. There were $26.70B in debt and $11.61B in liabilities at the time. Its Book Value Per Share was $14.67, while its Total Shareholder’s Equity was $21.06B.
Analysts Opinion
There may be slightly higher risks associated with pre-market and after-hours trading than during regular market hours. Due to the fact that issuers often announce critical financial information outside of regular trading hours, extended-hours trading may result in wider spreads for particular securities. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for GILD is Buy with a score of 4.15.
